CD14 and cancer: There are many biomarkers for renal clear cell carcinoma, for example, Ning Yi Yap et al. showed in a CD14 immunohistochemical assay of 88 pairs of renal clear cell carcinoma and their adjacent non-cancerous kidney tissues that CD14-positive tumors and immune cells were strongly associated with cancer progression42.